Masitinib for the treatment of Alzheimer's disease.
Ettcheto M, Cano A, Sanchez-López E, Verdaguer E, Folch J, Auladell C, Camins A.
Ettcheto M, et al. Among authors: camins a.
Neurodegener Dis Manag. 2021 Aug;11(4):263-276. doi: 10.2217/nmt-2021-0019. Epub 2021 Aug 20.
Neurodegener Dis Manag. 2021.
PMID: 34412534
Review.